Wockhardt Limited (BOM:532300)
India · Delayed Price · Currency is INR 2,151.85
+121.15 (5.97%)
At close: Jun 1, 2026
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 330.09 billion as of June 1, 2026. Its market cap has increased by 65.93% in one year.
Market Cap
330.09B
Enterprise Value
348.70B
Revenue
33.73B
Ranking
n/a
PE Ratio
154.97
Stock Price
2,151.85
Market Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 330.09B, an increase of 1,796.64%. That is a compound annual growth rate of 12.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 330.09B | 40.46% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lupin | 1.04T |
| Abbott India | 571.12B |
| GlaxoSmithKline Pharmaceuticals | 374.17B |
| J. B. Chemicals & Pharmaceuticals | 348.81B |
| AstraZeneca Pharma India | 216.79B |
| Granules India | 191.37B |
| Rubicon Research | 165.67B |
| Jubilant Pharmova | 157.38B |